Evidence map›Paper›PMID 10411918›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

An agouti mutation lacking the basic domain induces yellow pigmentation but not obesity in transgenic mice.

R J Miltenberger, R L Mynatt, B D Bruce, W O Wilkison, R P Woychik, E J Michaud

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Epigenomic disruption: the effects of early developmental exposures.Birth defects research. Part A, Clinical and molecular teratology · 2010
    Review
  4. Association of an Agouti allele with fawn or sable coat color in domestic dogs.Mammalian genome : official journal of the International Mammalian Genome Society · 2005
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

R J MiltenbergerLife Sciences Division, Oak Ridge National Laboratory, P.O. Box 2009, MS 8077, Oak Ridge, TN 37831, USA.
R L Mynatt
B D Bruce
W O Wilkison
R P Woychik
E J Michaud
Oak Ridge National Laboratory · USUniversity of Tennessee at Knoxville · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

Chronic antagonism of melanocortin receptors by the paracrine-acting agouti gene product induces both yellow fur and a maturity-onset obesity syndrome in mice that ubiquitously express wild-type agouti. Functional analysis of agouti mutations in transgenic mice indicate that the cysteine-rich C terminus, signal peptide, and glycosylation site are required for agouti activity in vivo. In contrast, no biological activity has been ascribed to the conserved basic domain. To examine the functional significance of the agouti basic domain, the entire 29-aa region was deleted from the agouti cDNA, and the resulting mutation (agoutiDeltabasic) was expressed in transgenic mice under the control of the beta-actin promoter (BAPaDeltabasic). Three independent lines of BAPaDeltabasic transgenic mice all developed some degree of yellow pigment in the fur, indicating that the agoutiDeltabasic protein was functional in vivo. However, none of the BAPaDeltabasic transgenic mice developed completely yellow fur, obesity, hyperinsulinemia, or hyperglycemia. High levels of agoutiDeltabasic expression in relevant tissues exceeded the level of agouti expression in obese viable yellow mice, suggesting that suboptimal activity or synthesis of the agoutiDeltabasic protein, rather than insufficient RNA synthesis, accounts for the phenotype of the BAPaDeltabasic transgenic mice. These findings implicate a functional role for the agouti basic domain in vivo, possibly influencing the biogenesis of secreted agouti protein or modulating protein-protein interactions that contribute to effective antagonism of melanocortin receptors.

Indexed as

Intercellular Signaling Peptides and ProteinsAgouti Signaling ProteinAnimalsBody WeightGene DosageGene ExpressionGlycosylationMiceMice, TransgenicMutationObesityPhenotypePigmentationPromoter Regions, GeneticProteinsProtein Sorting SignalsAgouti Signaling Proteina protein, mouseIntercellular Signaling Peptides and ProteinsProteinsProtein Sorting SignalsReceptors, CorticotropinReceptors, MelanocortinRNA

Identifiers

PMID10411918
PMCPMC17559
OpenAlexW2056193338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.